Mirum Pharmaceuticals Share Price Today
(NASDAQ: MIRM)

Name: Mirum Pharmaceuticals Share Price Today (NASDAQ: MIRM) - Mirum Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Mirum Pharmaceuticals share price is $39.1 & ₹3,341.68 as on 18 Apr 2025, 2.30 'hrs' IST

$39.1

▲

0.35

(0.9%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Mirum Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Mirum Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mirum Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Mirum Pharmaceuticals share price movements

Today's Low: $38.35
Today's High: $39.44
$39.10
1.92%
Downside
Day's Volatility :2.76%
Upside
0.86%
52 Weeks Low: $23.14
52 Weeks High: $54.23
$39.10
40.82%
Downside
52 Weeks Volatility :57.33%
Upside
27.91%

Mirum Pharmaceuticals (MIRM) Returns

Period	Mirum Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-18.51%	-2.8%	0.0%
6 Months	-0.64%	-11.0%	0.0%
1 Year	64.22%	-1.9%	0.0%
3 Years	53.21%	-1.5%	-12.9%

Mirum Pharmaceuticals (MIRM) Key Statistics

in dollars & INR

Previous Close	$38.75
Open	$38.67
Today's High	$39.44
Today's Low	$38.35
Market Capitalization	$1.9B
Today's Volume	$429.1K
52 Week High	$54.234
52 Week Low	$23.14
Revenue TTM	$336.9M
EBITDA	$-64.0M
Earnings Per Share (EPS)	$-1.85
Profit Margin	-26.1%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-37.08%

How to invest in Mirum Pharmaceuticals Stock (MIRM) from India?

It is very easy for Indian residents to invest directly in Mirum Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mirum Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mirum Pharmaceuticals or MIRM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mirum Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mirum Pharmaceuticals shares which would translate to 0.022 fractional shares of Mirum Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mirum Pharmaceuticals, in just a few clicks!

Returns in Mirum Pharmaceuticals (MIRM) for Indian investors in Rupees

The Mirum Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Mirum Pharmaceuticals investment value today

Current value as on today

₹1,66,558

Returns

₹66,558

(+66.56%)

Returns from Mirum Pharmaceuticals Stock

₹64,217 (+64.22%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Mirum Pharmaceuticals (MIRM)

-63%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Mirum Pharmaceuticals Stock from India on INDmoney has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Mirum Pharmaceuticals

HHG PLC
9.35%
BlackRock Inc
7.01%
Bvf Inc
5.71%
Eventide Asset Management, LLC
5.32%
Vanguard Group Inc
4.95%
Citadel Advisors Llc
3.08%

Analyst Recommendation on Mirum Pharmaceuticals

Rating

Trend

Buy

94%Buy

5%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Mirum Pharmaceuticals(by analysts ranked 0 to 5 stars)

Analyst Forecast on Mirum Pharmaceuticals Stock (MIRM)

What analysts predicted

Upside of 63.11%

Target:

$63.78

Current:

$39.10

Insights on Mirum Pharmaceuticals Stock (Ticker Symbol: MIRM)

Price Movement
In the last 1 year, MIRM stock has moved up by 62.7%
Increasing Revenue
Revenue is up for the last 4 quarters, 69.22M → 99.41M (in $), with an average increase of 11.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -14.23M → -23.79M (in $), with an average decrease of 67.1% per quarter
MIRM vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 13.4%
Price to Sales
ForMIRM every $1 of sales, investors are willing to pay $5.5, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Mirum Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Mirum Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Mirum Pharmaceuticals (MIRM) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Mirum Pharmaceuticals Inc	-18.32%	-0.64%	64.22%	53.21%	160.23%
Regeneron Pharmaceuticals, Inc.	-17.1%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-13.12%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.76%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-9.09%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Mirum Pharmaceuticals Inc	NA	NA	NA	-0.81	-0.37	-0.08	NA	4.67
Regeneron Pharmaceuticals, Inc.	14.68	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Mirum Pharmaceuticals Inc	Buy	$1.9B	160.23%	NA	-26.1%
Regeneron Pharmaceuticals, Inc.	Buy	$60.5B	-0.85%	14.68	31.07%
Beone Medicines Ltd	NA	$26.9B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	61.91%	NA	-12.37%

Mirum Pharmaceuticals Dividend announcements

Mirum Pharmaceuticals Earnings
Mirum Pharmaceuticals’s price-to-earnings ratio stands at None

About Mirum Pharmaceuticals

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally. The company is also involved in the commercialization of Cholbam, a cholic acid capsule, which is approved as treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects and for adjunctive treatment of patients with peroxisomal disorders, including peroxisome biogenesis disorder-Zellweger spectrum disorder and Smith-Lemli-Opitz syndrome; and Chenodal, a tablet, which is approved for the treatment of radiolucent stones in the gallbladder, and under Phase 3 development for the treatment cerebrotendinous xanthomatosis. In addition, it develops Volixibat, an oral and minimally absorbed agent designed to inhibit IBAT, currently under Phase 2b clinical trial for the treatment of adult patients with cholestatic liver diseases. The company was incorporated in 2018 and is headquartered in Foster City, California.

Organization	Mirum Pharmaceuticals
Employees	322
CEO	Mr. Christopher Peetz
Industry	Health Technology

Management People of Mirum Pharmaceuticals

Name	Title
Mr. Christopher Peetz	CEO & Director
Mr. Peter Radovich M.B.A., Ph.D.	COO & President
Mr. Eric H. Bjerkholt M.B.A.	Chief Financial Officer
Jolanda Howe	Senior VP & Global Controller

Important FAQs about investing in MIRM Stock from India :

What is Mirum Pharmaceuticals share price today?

Mirum Pharmaceuticals share price today stands at $39.10, Open: $38.67 ; Previous Close: $38.75 ; High: $39.44 ; Low: $38.35 ; 52 Week High: $54.23 ; 52 Week Low: $23.14.

The stock opens at $38.67, after a previous close of $38.75. The stock reached a daily high of $39.44 and a low of $38.35, with a 52-week high of $54.23 and a 52-week low of $23.14.

Can Indians buy Mirum Pharmaceuticals shares?

Yes, Indians can invest in the Mirum Pharmaceuticals (MIRM) from India.

With INDmoney, you can buy Mirum Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Mirum Pharmaceuticals at zero transaction cost.

How can I buy Mirum Pharmaceuticals shares from India?

It is very easy to buy Mirum Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mirum Pharmaceuticals (MIRM) be purchased?

Yes, you can buy fractional shares of Mirum Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Mirum Pharmaceuticals stocks?

To start investing in Mirum Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.